Some 2.6 million UK residents have diabetes and this number is rising. These people are at increased risk of heart disease, blindness and limb amputation. It is important to know the difference between Type I and Type II diabetes and how they can be managed to avoid these serious long-term complications. In this special report, you can find recent news and relevant articles about diabetes, including information about the condition and the treatment for it.
As part of The Pharmaceutical Journal and RB’s joint campaign on foot health, five healthcare professionals talk about their different approaches to discussing foot care with patients and the challenges they face.
The National Pharmacy Association has produced a series of tables to help pharmacists and staff select the correct insulin when dispensing against generic prescriptions.
Community and GP pharmacists have an important role in supporting annual diabetes checks, which are essential in helping early detection of diabetes-related complications, a consultant pharmacist specialising in diabetes and endocrinology has said.
The cholesterol and calorie hypotheses are both dead — it is time to focus on the real culprit: insulin resistance
Emerging evidence shows that insulin resistance is the most important predictor of cardiovascular and type 2 diabetes.
The learning materials are being developed in response to a survey that found many pharmacists do not feel confident discussing foot care, but would like to learn more.
Researchers have found that a repurposed anti-inflammatory and anti-allergic drug previously developed for asthma improved blood glucose control in people with type 2 diabetes and non-alcoholic fatty liver disease.
Trial data suggest treatment does not improve glycaemic control but may reduce risk factors for cardiovascular disease.
Blood sugar self-monitoring in non-insulin treated type 2 diabetes doesn’t improve controlSubscription
Trial shows no benefits to glycaemic control or health-related quality of life in patients who self-monitor glucose levels.
Children with type 1 diabetes are less likely to meet their HbA1c blood glucose target when their care transfers from paediatric to adult health services, according to the results of the first ever audit of its kind.
In a study comparing treatments for type 2 diabetes, SGLT2 inhibitors show double the risk of ketoacidosis versus gliptins.
A survey Diabetes UK has just conducted shows that most of us (59%) now know someone with type 2 diabetes. Yet most people would ignore four out of six symptoms of diabetes (thrush, fatigue, increased urination and extreme thirst).
A heat-detection mat that gives early warning of developing foot ulcers shows encouraging results, offering a useful tool in diabetic care.
The war with body fatSubscription
English Pharmacy Board meeting: 26 January 2017Subscription
Photopharmacology: using light to activate drugsSubscription
Building a case on the harm of sugarSubscription
The challenges of managing diabetes at mealtimesSubscription